Latest Strategy News

Aura Energy has secured a strategic non-binding MOU with a major international nuclear utility, underpinning funding and technical collaboration for its Tiris Uranium Project in Mauritania. The company has locked in a robust processing flowsheet and aims for a Final Investment Decision by the end of 2026.

Somerset Minerals has unveiled high-grade copper results up to 9.26% from its 2026 diamond drilling at Jura, Nunavut, while gearing up for maiden drilling at the extensive Talisker anomaly, signalling a busy exploration year ahead.

Evion Group has appointed former Australian Ambassador to the US, Arthur Sinodinos, as Strategic Advisor to accelerate its US critical minerals strategy following its acquisition of the CARP Fluorspar Project in Nevada.

Hamelin Gold has kicked off a 3,000-metre reverse circulation drilling program at its Day Dawn project in Western Australia's Paterson Province, aiming to validate and extend the high-grade Aurora Lode. The company plans follow-up drilling phases and deeper diamond drilling to explore a potential Telfer-style gold system.

Forrestania Resources has updated its MacPhersons deposit resource to 73,800 ounces, pushing its global JORC-compliant gold resource past the one million ounce mark. This milestone underscores the company’s growing footprint in Western Australia’s Eastern Goldfields.

AoFrio Limited has initiated a 1-for-7 renounceable rights offer at NZ$0.07 per share aiming to raise nearly NZ$5 million. This follows a recent $4.56 million placement and supports an aggressive growth strategy targeting $300 million revenue by 2030.

MFF Capital Investments’ May update shows a modest fall in net tangible assets per share and outlines a cautious yet optimistic portfolio stance amid geopolitical tensions and technological advances.

Corporate Travel Management reports progress on UK customer remediation with funding plans underway and final agreements near completion. The company maintains strong client retention above 97% and aims to release audited FY25 and reviewed 1H26 financials by end of June, eyeing a swift return to ASX trading.

Intelligent Monitoring Group (ASX:IMB) has finalized its A$37 million purchase of Wormald NZ and Red Wolf, expanding its New Zealand footprint and projecting a 20.9% accretion in earnings per share.

Optiscan and Mayo Clinic have completed all key engineering milestones in their two-year partnership to develop a digital endomicroscopic imaging system for robotic surgery, extending their agreement to support further clinical and commercial planning.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for eight of its Australian ETFs, detailing investment strategies, fees, risks, and operational protocols under ASX AQUA Rules.

ReNerve has inked an exclusive three-year deal with Hong Kong’s Swedish Trading Company to distribute its nerve repair products across a vast and dynamic healthcare region.